{"drugId":"CHEMBL1096882","targetId":"ENSG00000167325","diseaseId":"EFO_0000094","phase":1,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02924753%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"B-cell acute lymphoblastic leukemia","approvedSymbol":"RRM1","approvedName":"ribonucleotide reductase catalytic subunit M1","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL1421","targetId":"ENSG00000136573","diseaseId":"EFO_0004254","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00872976%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00829647%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","MONDO_0001014","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","EFO_0000096","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"chronic lymphocytic leukemia","approvedSymbol":"BLK","approvedName":"BLK proto-oncogene, Src family tyrosine kinase","targetClass":["Enzyme"],"prefName":"DASATINIB","tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"drugType":"Small molecule","mechanismOfAction":"SRC inhibitor","targetName":"SRC"}
{"drugId":"CHEMBL2107358","targetId":"ENSG00000129473","diseaseId":"MONDO_0100336","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00538187%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00612612%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","MONDO_0001014","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","EFO_0000096","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"chronic lymphocytic leukemia","approvedSymbol":"BCL2L2","approvedName":"BCL2 like 2","targetClass":["Other cytosolic protein"],"prefName":"OBATOCLAX MESYLATE","tradeNames":[],"synonyms":["GX-15-070MS","GX15-070MS","Obatoclax","Obatoclax mesilate","Obatoclax mesylate"],"drugType":"Small molecule","mechanismOfAction":"Apoptosis regulator Bcl-W inhibitor","targetName":"Apoptosis regulator Bcl-W"}
{"drugId":"CHEMBL3989869","targetId":"ENSG00000097007","diseaseId":"EFO_0000095","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02612311%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","MONDO_0001014","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","EFO_0000096","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"chronic lymphocytic leukemia","approvedSymbol":"ABL1","approvedName":"ABL proto-oncogene 1, non-receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"UMBRALISIB TOSYLATE","tradeNames":["Ukoniq"],"synonyms":["RP-5307","TGR-1202","TGR-1202 (4-METHYLBENZENESULFONATE)","Tgr-1202","Umbralisib tosylate"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase ABL inhibitor","targetName":"Tyrosine-protein kinase ABL"}
{"drugId":"CHEMBL408194","targetId":"ENSG00000171791","diseaseId":"EFO_0000095","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00612612%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00538187%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","MONDO_0001014","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","EFO_0000096","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"chronic lymphocytic leukemia","approvedSymbol":"BCL2","approvedName":"BCL2 apoptosis regulator","targetClass":["Ion channel"],"prefName":"OBATOCLAX","tradeNames":[],"synonyms":["GX15-070","Obatoclax"],"drugType":"Small molecule","mechanismOfAction":"Apoptosis regulator Bcl-2 inhibitor","targetName":"Apoptosis regulator Bcl-2"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000261456","diseaseId":"EFO_0000095","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003204%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","MONDO_0001014","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","EFO_0000096","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"chronic lymphocytic leukemia","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}